Filing Details

Accession Number:
0000904454-13-000778
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-02 19:30:53
Reporting Period:
2013-06-28
Filing Date:
2013-07-02
Accepted Time:
2013-07-02 19:30:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1262104 Mei Pharma Inc. MEIP Pharmaceutical Preparations (2834) 510407811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398936 Vivo Ventures V Affiliates Fund, L.p. 575 High Street
Suite 201
Palo Alto CA 94301
No No Yes No
1398937 Vivo Ventures Fund V, L.p. 575 High Street
Suite 201
Palo Alto CA 94301
No No Yes No
1399028 Vivo Ventures V, Llc 575 High Street
Suite 201
Palo Alto CA 94301
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-06-28 426 $7.58 231,216 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.48 to $7.65 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  2. Includes 228,846 shares held of record by Vivo Ventures Fund V, L.P., and 2,370 shares held of record by Vivo Ventures V Affiliates Fund, L.P. (together, the "Vivo V Funds"). Vivo Ventures V, LLC (the "Vivo V GP"), as the sole general partner of both of the Vivo V Funds, may be deemed to beneficially own the Common Stock of the Issuer owned by the Vivo V Funds. Vivo V GP disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein.